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Although this is a good start, more practical actions are still
required. Practical actions should include raising awareness,
advocating for more resource allocation and training at a
national level, building injury research groups at research
institutes/universities, and developing injury prevention
needs assessments at a community level. A partnership of
international agencies and injury prevention research
scientists around the world will benefit individuals and
communities, both in Pakistan and globally.4
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Abstract
Objective: To determine predictors of need for transfusion of blood and blood products and create a clinical
predictive model to reduce indiscriminate use of blood products during surgery.
Method: We conducted a retrospective chart review of 485 patients who underwent coronary artery bypass
surgery from January 2004 to December 2004 at a Tertiary Care Hospital in Karachi, Pakistan. Independent
predictors associated with transfusion were identified and a clinical prediction model developed.
Results: The transfusion rate was 37.1%. A predictive model was created based on the presence of pulmonary
disease, diabetes mellitus, low ejection fraction and recent/ongoing myocardial infarction.
Conclusion: The study identifies some predictors of need for blood transfusion in patients undergoing Coronary
Artery Bypass Grafting. However, prospective studies with a larger sample of patients are needed to determine
other predictors and their applicability in patient selection across institutions (JPMA 58:421;2008).

Introduction
Coronary artery bypass-graft surgery (CABG)
currently is the commonest cardiac operation performed in
the adult population.1 There have been great advances in
perfecting this surgery leading to reduced number of
complications. However, the complications related to blood
transfusion are still high. According to international figures,
use of blood transfusions for cardiac patients is as high as
10-40%, presumably higher in Pakistan considering the lack
of blood conservation strategies.2,3 The patients requiring
blood transfusion make up more than one third of those
going for elective CABG.4
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Transfusion of blood or its products are reported as
the most important factor associated with increased risk of
postoperative morbidity and mortality following a coronary
artery bypass graft surgery.5,6 The risks associated with
transfusion include infectious disease transmission, acute
and delayed haemolytic reactions, transfusion-related acute
lung injury and transfusion related immunomodulation.7,8
These morbidities not only affect the patient's quality of life
and risk of death after the procedure but also add a huge cost
burden especially if a lifelong infection is acquired.
Blood
conservation
techniques
including
preoperative autologous blood donation (PABD),
intraoperative use of antifibrinolytic drugs, hypervolaemic
421

haemodilution, preoperative erythropoietin administration
and acute normovolaemic haemodilution are expensive and
carry their own risks.9,10 It is therefore imperative to have a
model that selects patients for such procedures and patients
who will eventually need a transfusion.
At the same time, risks related with use of blood in
Pakistan are higher than the developed world. The
prevalence of Hepatitis B exposure determined by AntiHBc prevalence in healthy blood donors is reported to be as
high as 17% and at the same time, not all blood bank
facilities are well equipped for infectious disease detection
in donors.11,12 An average patient receiving two units of
blood has a 10% chance of acquiring hepatitis C infection.11
It is obvious that transfusion related risks are higher in the
country than reported in the literature. To the best of our
knowledge, no study has been conducted to explore the
predictors for use of blood products in patients undergoing
CABG in Pakistan.
Several studies have explored predictors for the use
of blood and blood products in patients undergoing CABG.
The various predictors include preoperative haemoglobin,
red cell mass, body mass index, body surface area, female
sex, age, extent of disease, number of diseased vessels,
prior CABG, redo procedure, emergent operation, diabetes
and renal disease, extent of acute normovolaemic
haemodilution, use of cardiopulmonary bypass, ejection
fraction
albumin,
preoperative
antiplatelet
or
antithrombotic drugs and preoperative bleeding and
prothrombin times2,13-17 the above predicators cannot be
applied to our population , as the demographics and
outcome of surgery may be variable.
We aimed to determine the predictors of transfusion
of blood and blood products in patients undergoing CABG
in a tertiary care centre in Pakistan and develop a clinical
prediction model for use of blood products in patients
undergoing CABG.

Patients and Methods
After institutional ethics approval, data on
consecutive patients who had undergone CABG surgery at
a tertiary care hospital, from January 2004 to December
2004 was retrieved retrospectively. All patients undergoing
CABG surgery during this time period at were included.
Those with missing record files and unclear or incomplete
information were excluded.
The study was conducted in a tertiary care teaching
hospital (representing private sector) of Karachi, Pakistan.
A total of 510 open-heart surgical procedures were
performed during the study year at this institution. Bloodconservation methods used before surgery included
discontinuation of anti-platelet and anticoagulant
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medication 1 week prior to surgery and screening for and
correction of coagulation disorders. Blood-conservation
methods used during surgery included the administration of
antifibrinolytic agents (tranexamic acid and aprotinin). On
routine, recycled pumped blood was used in all patients.
Blood was transfused in patients with haemoglobin levels
less than 10 mg/dl if off-pump and 7 mg/dl if on-pump.
Platelets and fresh frozen plasma was empirically
given to any patient who had episode of bleeding post
operatively.
The exposure variables were divided into continuous
and categorical variables. The continuous variables
included age (years), Body Mass Index (kg/m2),
preoperative haemoglobin (g/dl), preoperative platelet,
preoperative prothrombin time, preoperative activated
partial thromboplastin time, preoperative bleeding time,
ejection fraction, cardio-pulmonary bypass duration (min)
and aortic clamp duration (min).
The categorical variables included gender, use of
anti-platelets, anticoagulant or antithrombotic agents
(defined as more than 2 weeks of use of the agent prior to the
surgery), coagulation defects ( history of any coagulopathy
or objective evidence of coagulation defect pre-operatively),
smoking (ex and current smokers combined), renal
dysfunction ( defined as Cr>1.1 mg/dl), hypertension
(history of hypertension and being on antihypertensive
therapy at the time of surgery), peripheral vascular disease
(defined as a history of claudication, ischaemic resting pain,
vascular surgery or a non invasive vascular test showing >
50% obstruction of the lower extremity vasculator), carotid
artery disease (Carotid doppler proven > 70% stenosis of
carotid artery), diabetes mellitus (as history of diabetes
mellitus, Type I or II, and being on medication at the time of
surgery), pulmonary disease (known history of pulmonary
disease or FEV1 < 1.5 L at the time of surgery), recent/
ongoing myocardial infarction (based on EKG changes and
Trop I > 0.5 ng/ml), type of surgery defined as urgent,
emergent or elective and catheterization during admission.
All variables except gender and type of surgery were
binomial variables defined as Yes/No.
The primary outcome measure was blood
transfusion given intra-operatively or post-operatively.
Preoperative and peri-operative patient variables
previously reported to be associated with the need for blood
transfusion during CABG and other cardiac surgeries were
determined along with variables which revealed a
statistically significant association. Database accuracy was
measured by re-abstracting a random sample of 10 percent
of the medical records of CABG patients. In addition, all
outlying values were compared to patients' records to
identify and correct errors in the database.
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SPSS 15.0 (copyright © SPSS Inc., 1989-2007) was
used for statistical analysis.
Results were expressed as mean ± standard deviation
for all continuous variables and frequency and percentage for
categorical data. Univariate analysis was performed by using
the independent sample t-test, Pearson Chi-square test and
Fisher Exact test wherever appropriate to assess the unadjusted
relationship between the predictor variables and the outcome.
A p-value <0.05 was considered as statistically significant.
The initial model was derived by using all
statistically significant (p<0.25, the standard criterion for
selection of candidate variables to be used in multivariate
analysis) predictor variables that were not confounding with
other variables. The best fitting model was identified from
different models, each derived from different predictor
variables. The Hosmer and Lemeshow goodness-of-fit test
was also used to determine the final model.18

Results
Among 485 patients 82.5% (n=400) were male and
17.5% (n=85) female. The mean age of the patients was 58.
5 ± 9.6 years. Mean Body Mass Index of the patient
population was 26.6 ± 4.5 kg/m2. Out of 485 CABG
surgeries performed during the study period selected 68.9
%( n=334) were elective, 22.3% (n=108) were urgent and
8.9% (n=43) emergency.
Of the 485 patients undergoing CABG, 21.0% (n=
102) patients had acute coronary syndrome with 19.8%
(n=96) having a recent or ongoing myocardial infarction at
the time of presentation.
Hypertension was a common comorbid seen in 70.7%
(n= 343) of the patients while 43.1% (n=209) had diabetes,
39.0% (n= 189) had dyslipidaemia, 4.5% (n=22) had renal
disease, 1% (n=5) had carotid artery disease and 6.6 %(
n=32) patients had pulmonary disease, whereas 2.1% (n=10)

of the patients had a history of previous coronary bypass
surgery. Mean preoperative haemoglobin and haematocrit
level of the patients were 12.8 ± 1.8mg/dl and 38.6 ± 73.4%
respectively. The mean International Normalized Ratio was
1.02 ± 0.13. 73.4% (n= 356) of the patients were exposed to
some form of anteplatelet therapy prior to the surgery. Among
this group, majority (95.2%) had taken aspirin. These
medications were stopped in 68.2% (n= 331) patients at a
mean of 5 days before the surgery was performed.
Majority of the procedures were carried out using the
conventional technique, (only a small proportion (2.3%;
n=11) used the off pump technique. Mean cardiopulmonary
bypass time was 99.1 ± 31.9 minutes. Aortic Cross Clamp
time was 59.9 ± 20.7 minutes. Intra-aortic Balloon Pump
(IABP) use was found in 9.1% (n=44) cases. Blood or blood
products were used in 37.1% (n= 180) of the patients.
The complications of surgery occurred in 9.9%
(n=48) patients. 45.8% of these suffered from hemorrhage.
On univariate analysis presence of diabetes mellitus
differed significantly between the patients who required
blood transfusions and who did not. Also, ejection fraction,
presence of pulmonary disease, prothrombin time,
recent/ongoing myocardial infarction differed between the
two groups, however, it was not significant. We found no
interaction among the variables used in univariate analysis.
The comparison of all variables between the two groups is
shown in Tables 1 and 2.
We applied multiple logistic regression on all the
significant variables to put together a predictive model for
transfusion requirement during CABG. Hence, after
removing all the confounded variables, a model consisting
of diabetes mellitus, pulmonary disease, ejection fraction
and recent/ongoing myocardial infarction were found as
predicting factors for need of blood transfusion in patients
undergoing CABG surgery (Table 3).

Table 1. Unadjusted relationship of continuous variables with transfusion (n=485)
Variable

Transfused (180,37.1)

Not transfused (305, 62.9)

p value

Age (years)

58.9 ±9.3

58.3±9.7

0.52

Body Mass Index (kg/m2)

26.9±5.0

26.5±4.1

0.42

Preoperative Hemoglobin (g/dl)

12.6±1.9

12.9±1.7

0.15

250.7±69.7

241.6±72.4

0.19

Preoperative Prothrombin Time (sec)

12.1±1.0

12.3±1.8

0.07

Preoperative Activated Partial Thromboplastin Time (sec)

30.6±5.3

30.2±6.0

0.48

Preoperative Bleeding Time (sec)

3.0±1.5

3.2±1.7

0.15

Ejection Fraction (%)
Perioperative variables

50.3±10.6

48.4±11.8

0.07

Cardiopulmonary Bypass Duration (min)

101.1±35.3

97.9±29.7

0.31

Aortic clamp Duration (min)

60.7±24.1

59.4±18.5

0.53

Patient variables

Preoperative Platelet (x109/l)
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Table 2. Unadjusted relationship of categorical variables with transfusion (n=485).
Variable

Transfused

Not transfused

Odds Ratio (OR) Confidence Interval (95% CI)

148 (82.2)
32 (17.8)

252 (82.6)
53 (17.4)

1.0
1.0

0.6-1.7

55 (30.6)
125 (69.4)

74 (24.3)
231 (75.7)

1.0
0.73

0.5-1.1

154 (85.6)
26 (14.4)

253 (83.0)
52 (17.0)

1.0
0.82

0.5-1.3

1 (0.6)
179 (99.4)

2 (0.7)
303 (99.3)

1.0
1.2

0.1-13.1

178 (98.9)
2 (1.1)

301 (98.7)
4 (1.3)

1.0
0.9

0.2-4.7

176 (97.8)
4 (2.2)

299 (98.0)
6 (2)

1
1.1

0.3-4.1

114 (63.3)
66 (36.7)

195 (63.9)
110 (36.1)

1.0
1.0

0.7-1.5

173 (96.1)
7 (3.9)

290 (95.1)
15 (4.9)

1.0
0.8

0.3-2.0

48 (26.7)
132 (73.3)

94 (30.8)
211 (69.2)

1.0
1.2

0.8-1.9

179 (99.4)
1 (0.6)

305 (100.0)
0

178 (98.9)
2 (1.1)

302 (99.0)
3 (1.0)

1.0
1.1

0.2-6.8

91 (50.6)
89 (49.4)

185 (60.7)
120 (39.3)

1.0
1.5

1.0-2.2

163 (90.6)
17 (9.4)

290 (95.1)
15 (4.9)

1.0
2.0

1.0-4.1

137 (76.1)
43 (23.9)

252 (82.6)
53 (17.4)

1.0
1.5

0.95-2.4

18 (10.0)
39 (21.7)
123 (68.3)

25 (8.2)
69 (22.6)
211 (69.2)

1.0
1.2
1.0

0.7-2.4
0.6-1.5

139 (77.2)
41 (22.8)

230 (75.4)
75 (24.6)

1.0
0.91

0.6-1.4

P-value

Patient variables
Gender
Male
Female

0.91

Preoperative variables
Anti platelet usage
No
Yes
Anti coagulant usage
No
Yes
Thrombolytic usage
No
Yes
Coagulation defects present
No
Yes
Re-operation
No
Yes
Smoking
No
Yes
Renal dysfunction
No
Yes
Hypertension
No
Yes
Peripheral Vascular disease
No
Yes
Carotid artery disease
No
Yes
Diabetes Mellitus
No
Yes
Pulmonary disease
No
Yes
Recent/ongoing Myocardial Infarction
No
Yes

0.13

0.45

0.89

0.85

0.85

0.89

0.6

0.33

0.89

0.03

0.06

0.08

Perioperative variables
Type of surgery
Elective
Emergency
Urgent
Catheterization during admission
No
Yes
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0.79

0.65
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Table 3. Final multiple logistic regression model selected for the
prediction rule*
Variable

Odds ratio

95% CI

P value

Diabetes Mellitus

1.6

1.1-2.3

0.021

Pulmonary disease

2.1

1.0-4.4

0.048

Ejection fraction

1.0

1.0-1.0

0.028

Recent / ongoing Myocardial
Infarction

1.5

1.0-2.4

0.071

Discussion
Variability of transfusion rate in different institutions
has been demonstrated frequently in literature.3 The
differences have been attributed to adherence to different
blood saving techniques and adherence to different
guidelines, availability of products and quality of surgical
care to the patients. The rate of 37.1% in our study setting is
comparable to Karkouti et al where strict guidelines for
blood conservation were employed.19
However, we found very few similarities with
previous studies while looking at independent predictors of
need for blood transfusion in our study. For instance, factors
associated with reduced red cell volume including a low
HB, Haematocrit and red cell mass have been significantly
associated with need for blood transfusion in other
studies.13-15,19 This lack of association in our data could be
attributed to low threshold of haemoglobin levels and
haematocrit levels for blood transfusion practiced in our
institution.
A lack of association of need of transfusion with sex
was also different from other similar studies conducted in
other countries. But this result must be interpreted with
caution as the state of revascularization surgeries for
females was drastically lower than those of males in the
study. This could not have been controlled as fewer women
than men suffer from serious heart disease to require cardiac
revascularization procedures in a year.
The factors found to be significantly associated with
need for blood products in our study are unrelated to each
other and hence may add to the strength of the clinical
predictive model. Ejection fraction being an independent
predictor is not a novel finding and is consistent with other
studies. A poorer outcome in patients with a low ejection
fraction has previously been established and hence this
group of patients becomes high risk for operative and
postoperative complications.20 A higher risk of blood
transfusion with a low ejection fraction is a result of limited
reserve of blood pumping power to meet the demands of
vital end organs and hence early transfusion becomes
essential.
A recent/ on going myocardial infarction could be
explained partially by its effect on the ejection fraction and
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the overall efficiency of systemic circulation and partially
by instability of vital signs as a result of a recent
cardiovascular episode.
The other two factors, presence of pulmonary
disease and diabetes mellitus are difficult to explain
biologically but nonetheless were seen be independently
associated with need for blood transfusion for the
procedure. A compromise of vascularity and reserve of
oxygenation of end organs remains a hypothesis.
The differences seen between our study and the rest
of the literature is also attributed to major differences in the
populations where these studies were conducted. Therefore,
not all predictors significantly associated with transfusion in
other settings could play a role in our setting of South Asian
population.
What is important to note is that this study is the first
of is kind ever done in a large tertiary care hospital of the
South Asian region and has provided a clinical predictive
model that will benefit surgeons and anaesthesiologists in
decision making for transfusion for their patients. Hence
they can rely on local experience along with international
blood conservation guidelines, which may or may not be
valid for our population. This study also highlights presence
of high variability of transfusion practice, predictors of
transfusion and predictive models across populations and
institutions.
The retrospective study design and data from a
single private tertiary care hospital are limitations of the
study. Major differences exist in private and public hospitals
and between different parts of the country and therefore
limits the applicability of this model nationally. Also,
predictive factors of use of whole blood and those of blood
products may be potentially different but this was not
assessed separately in our study. However, we found our
results comparable with other similar studies conducted in
which this separation of predictive models of different
blood products was not assessed.2,13,19

Conclusion
Employing a clinical predictive model and following
blood conservation guidelines can help to select the right
patients who need transfusion during CABG surgery. The
prediction rule comprises of presence of pulmonary disease,
diabetes mellitus, ongoing/recent myocardial infarction and
a low ejection fraction. This rule needs to be validated to
assess its applicability. Gender differences in need of
transfusion also need to be explored.
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Correlation of age at menarche and height in Iranian student girls living
in Gorgan -Northeast of Iran
Anneh Mohammad Gharravi1, Salimeh Gharravi2, Abdoljalal Marjani3, Abdolvahab Moradi4, Mohammad Jafar Golalipour5
Department of Anatomy1,5, Department of Biochemistry3, Department of Microbiology4, School of Medicine, Gorgan University of Medical Sciences
Gorgan, Iran, School of Health2, Gorgan University of Medical Sciences, Gorgan, Iran.

Abstract
Objective: To see the association of age at menarche with adult height in girls living in Gorgan - North of Iran.
Methods: This study included 100 female university students (aged 18-21 years) born between 1985-1988 and
200 intermediate school students (aged 12-15 years) born between 1992-1994. Age at menarche and its
association with height were studied. Data was analyzed by SPSS v11. 5 software. Pearson correlation was used
to determine the relation between menarcheal age and height.
Results: There was a significant difference in the age of menarche between intermediate school students (12.20
+ 1.45 years) and university students (13.54 + 1.30 years). This decreased by 68.54 days per 1-year. The
significant positive association was between age at menarche and height. Height of students with menarche at
an earlier age was less (P<0. 05). There was no significant difference in menarche age in the different
socioeconomic classes.
Conclusion: Girls living in Gorgan - North of Iran acquire menarche at an early age. Students with earlier
menarche reach a shorter adult height (JPMA 58:426;2008).

Introduction
Menarche at an early age is a risk factor for breast
cancer and overweight.1,2 Furthermore, early maturation is
an important public health concern because of its
relationship with early beginning of sexual activity. Studies
have found that hormonal changes at puberty influence
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ovarian cancer risk particularly in younger women. Ovarian
cancer seems to be associated with age at menarche and
attained adult height.3
Several studies have documented a trend towards
earlier pubertal development in developed countries. This
decline in puberty age has been observed in developing
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